News

October 4, 2018

Adcetris Added to Front-line Chemo Significantly Improves Survival in PTCL Patients, Phase 3 Trial Shows

News

Adcetris (brentuximab vedotin) as an add-on to first-line chemotherapy significantly extends the time to disease worsening or death in patients with peripheral T-cell lymphoma (PTCL) whose tumors are positive ... Read more

October 3, 2018

Adcetris-Gemcitabine Combo Eliminates Cancer in Two-thirds of Hodgkin’s Lymphoma Patients in Phase 1/2 Trial

News

A combination of Adcetris (brentuximab vedotin) and the chemotherapy gemcitabine completely eliminated the tumors in two out of three children and young adults with Hodgkin’s lymphoma in a Phase ... Read more

October 2, 2018October 2, 2018

Abdominal Obesity Better Than BMI at Predicting Risk for Blood Diseases, Study Shows

News

Measuring abdominal fat (obesity), including waist circumference, is a better predictor of the risk of developing hematological malignancies, especially multiple myeloma, than body mass index (BMI), according to a ... Read more

October 1, 2018October 3, 2018

FDA Approves Copiktra Capsules for 2 Lymphoma Types, Verastem Announces

News

The U.S. Food and Drug Administration approved Copiktra (duvelisib) capsules for the treatment of adults with relapsed or refractory chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) after a minimum of two prior ... Read more

September 27, 2018September 29, 2018

Burlington, Leukemia & Lymphoma Society Team Up to Raise Funds, Support Young Survivors

News

Coinciding with National Blood Cancer Awareness Month, Burlington Stores and the Leukemia & Lymphoma Society (LLS) are once again partnering in the quest to raise funds for blood cancer research ... Read more

September 26, 2018

Adcetris, Chemo Combo Approved in Japan for Untreated, Advanced Hodgkin’s Lymphoma

News

The Japanese Ministry of Health, Labour and Welfare has approved the use of Adcetris (brentuximab vedotin) in combination with standard chemotherapy as a frontline treatment for CD30-positive Hodgkin’s lymphoma ... Read more

September 25, 2018

NICE Rejects Kymriah for England’s NHS to Treat Aggressive DLBCL

News

Kymriah (tisagenlecleucel), developed by Novartis, has not been recommended as a treatment for adults with aggressive diffuse large B-cell lymphoma (DLBCL) for England’s National Health Service (NHS). The National Institute for ... Read more

September 24, 2018

Adcetris May Increase Risk of Lung Toxicity in Younger Hodgkin’s Lymphoma Patients, Study Suggests

News

Adcetris (brentuximab vedotin) treatment may increase the chances of lung toxicity in children and young adults with relapsed or refractory Hodgkin’s lymphoma, a small retrospective study suggests. The study, ... Read more

September 21, 2018

Chemotherapy Used to Treat Hodgkin’s Lymphoma in Women Age 35 or Older Risks Damage to Ovaries, Study Finds

News

Damage to the ovaries is likely in women with Hodgkin’s lymphoma who are 35 years old or older and given standard chemotherapy, and in those at any age treated with BEACOPP chemotherapy, a secondary ... Read more

September 20, 2018

Older Stem Cell Transplant Patients with Non-Hodgkin’s Lymphoma at Higher Risk of Death, Study Suggests

News

Stem cell transplant to treat non-Hodgkin’s lymphoma in patients older than 65 is as effective as it is in younger patients, but is associated with a higher risk of ... Read more

Pin It on Pinterest